Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.420
+0.010 (0.71%)
Jan 7, 2026, 2:50 PM EST - Market open
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $125.35 million as of January 7, 2026. Its market cap has increased by 420.17% in one year.
Market Cap
125.35M
Enterprise Value
85.51M
1-Year Change
420.17%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $125.35M, a decrease of -51.12%. That is a compound annual growth rate of -15.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 124.47M | 4.44% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |